Clinical Trials on Complex Endometrial Hyperplasia With Atypia

Total 395 results

Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia

Stage II Uterine Corpus Cancer | Stage IA Uterine Corpus Cancer | Stage IB Uterine Corpus Cancer | Complex Endometrial Hyperplasia With Atypia

United States
Pirogov Russian National Research Medical University

Completed

Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes

Endometrial Cancer | Endometrial Hyperplasia Without Atypia | Postmenopause | Peripheral Blood Mononuclear Cells | Endometrial Hyperplasia With Atypia | Estrogen Receptor | Progesterone Receptor
Queensland Centre for Gynaecological Cancer
The University of Queensland; Queensland University of Technology

Active, not recruiting

Improving the Treatment for Women With Early Stage Cancer of the Uterus (feMMe)

Complex Endometrial Hyperplasia With Atypia | Grade 1 Endometrial Endometrioid Adenocarcinoma

Australia, New Zealand
Kocaeli University

Completed

Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia

Endometrial Hyperplasia Without Atypia

Turkey
Xiaojun Chen

Completed

MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

Endometrial Hyperplasia Without Atypia

China
UNC Lineberger Comprehensive Cancer Center

Completed

Metformin for the Treatment of Endometrial Hyperplasia

Endometrial Hyperplasia | Endometrial Hyperplasia Without Atypia

United States
Regina Elena Cancer Institute
Fondazione Policlinico Universitario Agostino Gemelli IRCCS; University of... and other collaborators

Active, not recruiting

Endometrial Changes in Breast Cancer Women.

Breast Cancer | Endometrial Cancer | Endometrial Hyperplasia With Atypia | TAM

Italy
Zagazig University

Completed

LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia

Egypt
Fudan University
Zhejiang Cancer Hospital; Shanghai 6th People's Hospital; Shanghai Changning...

Completed

Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia

Atypical Endometrial Hyperplasia

China
IRCCS Burlo Garofolo

Completed

Resectoscopic Treatment of Atypical Endometrial Polyps in Fertile Women

Atypical Endometrial Hyperplasia | Atypical Endometrial Polyps

Italy
Fudan University

Terminated

Metformin Plus Megestrol Acetate as a Fertility-sparing Treatment in Patients With Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia

China
West China Second University Hospital

Recruiting

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

Atypical Endometrial Hyperplasia | Endometrial Cancer

China
Women and Infants Hospital of Rhode Island

Unknown

The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy

Grade 1 Endometrial Endometrioid Adenocarcinoma | Grade 2 Endometrial Endometrioid Adenocarcinoma | Complex Atypical Endometrial Hyperplasia

United States
Krankenhaus Barmherzige Schwestern Linz

Completed

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

Endometrial Cancer | Atypical Hyperplasia

Austria
Xiaojun Chen
Huashan Hospital

Withdrawn

Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia

Atypical Endometrial Hyperplasia | Fertility Issues | Obese
University of the Philippines
Organon

Not yet recruiting

The Use of Etonogestrel Contraceptive Implant as Treatment for Endometrial Hyperplasia Without Atypia: A Cohort Study

Endometrial Hyperplasia Without Atypia
UNC Lineberger Comprehensive Cancer Center
Radiological Society of North America

Recruiting

18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy

Endometrial Cancer | Complex Atypical Hyperplasia

United States
UNC Lineberger Comprehensive Cancer Center
Golfers Against Cancer Grant

Active, not recruiting

Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients

Endometrial Cancer | Complex Atypical Hyperplasia

United States
Peking University People's Hospital

Recruiting

Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia | Endometrial Carcinoma Stage I

China
National Cancer Institute (NCI)

Active, not recruiting

Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer

Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Atypical Hyperplasia

United States
NYU Langone Health

Completed

Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate

Atypical Endometrial Hyperplasia | Endometrial Carcinoma

United States
Beijing Obstetrics and Gynecology Hospital

Not yet recruiting

Conservative Treatment for Atypical Endometrial Hyperplasia and Early Endometrial Cancer

Atypical Endometrial Hyperplasia and Endometrial Cancer
Fudan University

Completed

Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia

China
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy

Atypical Endometrial Hyperplasia | Endometrial Carcinoma

United States
Peking University People's Hospital
Peking University; Beihang University

Recruiting

Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer

Atypical Endometrial Hyperplasia | Endometrial Carcinoma Stage I

China
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer

Atypical Endometrial Hyperplasia | Recurrent Endometrial Carcinoma | Endometrial Adenocarcinoma | Stage IA Endometrial Carcinoma | Stage IB Endometrial Carcinoma | Stage II Endometrial Carcinoma | Stage IIIA Endometrial Carcinoma | Stage IIIB Endometrial Carcinoma | Stage IIIC Endometrial Carcinoma | Stage... and other conditions
University Health Network, Toronto

Recruiting

Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium (B-FiERCE)

Bariatric Surgery Candidate | Endometrial Cancer | Atypical Hyperplasia

Canada
Xiaojun Chen

Recruiting

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

Atypical Endometrial Hyperplasia | Endometrial Neoplasms | Progesterone Resistance

China
Sohag University

Not yet recruiting

the Value of Immunohistochemical Expression of Moesin in Endometrial Hyperplasia and Endometrial Carcinoma

Endometrial Cancer and Endometrial Hyperplasia

Egypt
CHU de Reims

Unknown

Role of Senescence in the Development of Endometrial Cancer

Endometrial Hyperplasia and Endometrial Cancers

France
Peking University People's Hospital

Recruiting

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I

China
University Health Network, Toronto

Not yet recruiting

Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium (WE-FiERCE)

Endometrial Cancer | Atypical Hyperplasia
Xiaojun Chen

Recruiting

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients

Obesity | Atypical Endometrial Hyperplasia | Progesterone Resistance

China
Fudan University

Recruiting

Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia

Obesity | Atypical Endometrial Hyperplasia | Fertility Issues

China
Xiaojun Chen

Recruiting

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Obesity | Atypical Endometrial Hyperplasia | Endometrial Neoplasms | Progesterone Resistance

China
Xiaojun Chen

Recruiting

Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia

Atypical Endometrial Hyperplasia | Fertility Issues | Overweight and Obesity

China
Xiaojun Chen
Zhejiang Cancer Hospital; Fudan University; Shanghai 6th People's Hospital; Shanghai...

Completed

Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma

Endometrial Adenocarcinoma | Endometrial Atypical Hyperplasia

China
Sohag University

Completed

Diagnostic and Prognostic Value of PTEN Expression in Functional and Pathological Endometrial Biopsies

Endometrial Hyperplasia | Endometrial Adenocarcinoma

Egypt
Imperial College London

Recruiting

Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy?

Endometrial Hyperplasia | Endometrial Neoplasms | Endometrial Cancer | Endometrial Polyp

United Kingdom
Imperial College London

Completed

Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue?

Endometrial Hyperplasia | Endometrial Neoplasms | Endometrial Cancer | Endometrial Diseases

United Kingdom
Nottingham University Hospitals NHS Trust

Recruiting

Vibrational Spectroscopy for Endometrial Cancer Diagnosis (SPEED)

Endometrial Hyperplasia | Endometrial Cancer

United Kingdom
Imperial College London

Unknown

Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer?

Endometrial Hyperplasia | Endometrial Neoplasms | Endometrial Cancer

United Kingdom
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer (LEVER)

Atypical Endometrial Hyperplasia | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma

United States
Rabin Medical Center
Ferring Pharmaceuticals

Unknown

Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen

Endometrial Hyperplasia | Endometrial Cancer

Israel
Assiut University

Recruiting

Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer

Endometrial Cancer

Egypt
Vancouver Coastal Health Research Institute
University of British Columbia

Recruiting

Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia (FETCH)

Gynecologic Cancer | Endometrial Hyperplasia | Endometrial Cancer

Canada
Kayseri Education and Research Hospital

Unknown

Irisin Hormone Levels in Endometrial Hyperplasia

Endometrial Hyperplasia

Turkey
Milton S. Hershey Medical Center
Center for Research on Women and Health

Terminated

Ultrasound and Endometrial Hyperplasia

Endometrial Hyperplasia

United States
Korean Gynecologic Oncology Group

Unknown

Management of Endometrial Hyperplasia With a LNG-IUS: Multicenter Study: KGOG2006 (KGOG2006)

Endometrial Hyperplasia

Korea, Republic of
Mansoura University

Completed

Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women

Endometrial Hyperplasia

Egypt

Clinical Trials on Complex Endometrial Hyperplasia With Atypia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations